Sources | Names Used |
---|---|
CTRPv2 | navitoclax:piperlongumine (1:1 mol/mol) |
PharmacoGx | navitoclax:piperlongumine (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C2CD4C | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-09 |
mRNA | MTX1 | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-09 |
mRNA | MBTD1 | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-09 |
mRNA | SLC25A29 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | TMSB15B | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | FANCF | CTRPv2 | pan-cancer | AAC | 0.22 | 3e-09 |
mRNA | ZNF836 | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
mRNA | ZNF713 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |
mRNA | RUNDC3A | CTRPv2 | pan-cancer | AAC | 0.22 | 4e-09 |
mRNA | TULP4 | CTRPv2 | pan-cancer | AAC | 0.21 | 4e-09 |